학술논문
1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1167-S1168
Subject
Language
ISSN
0923-7534